Free Trial

First Eagle Investment Management LLC Acquires New Shares in Envista Holdings Corporation $NVST

Envista logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • First Eagle Investment Management LLC opened a new position of 212,500 shares in Envista during Q3, worth about $4.33 million and representing roughly 0.13% of the company.
  • Insider sale: SVP Mischa Reis sold 9,675 shares at an average $30 on Feb. 10, cutting their holding by 23% (corporate insiders now own about 0.66% of Envista).
  • Wall Street sentiment is a Moderate Buy with an average target of $27.08 (analyst targets range about $19–$35); this follows a quarterly earnings beat and Envista's FY26 guidance of 1.350–1.450 EPS.
  • Interested in Envista? Here are five stocks we like better.

First Eagle Investment Management LLC acquired a new position in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 212,500 shares of the company's stock, valued at approximately $4,329,000. First Eagle Investment Management LLC owned about 0.13% of Envista at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its position in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company's stock worth $51,000 after acquiring an additional 638 shares during the last quarter. Claret Asset Management Corp boosted its stake in Envista by 6.5% during the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company's stock valued at $231,000 after purchasing an additional 724 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after purchasing an additional 949 shares during the last quarter. Farther Finance Advisors LLC increased its stake in shares of Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company's stock valued at $27,000 after purchasing an additional 1,026 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its holdings in shares of Envista by 5.9% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 21,283 shares of the company's stock valued at $434,000 after buying an additional 1,183 shares during the last quarter.

Insider Activity

In other Envista news, SVP Mischa Reis sold 9,675 shares of the company's stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company's stock, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. William Blair upgraded Envista from a "hold" rating to an "outperform" rating in a research report on Friday, February 6th. Mizuho increased their price target on Envista from $24.00 to $27.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 10th. Leerink Partners set a $35.00 price objective on shares of Envista and gave the company an "outperform" rating in a research note on Friday, February 6th. Weiss Ratings upgraded shares of Envista from a "sell (d)" rating to a "hold (c-)" rating in a research report on Tuesday, February 17th. Finally, Morgan Stanley set a $19.00 target price on shares of Envista in a research note on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $27.08.

View Our Latest Research Report on Envista

Envista Price Performance

Shares of Envista stock opened at $28.43 on Thursday. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $30.42. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. The stock has a market cap of $4.66 billion, a PE ratio of 101.54, a price-to-earnings-growth ratio of 1.96 and a beta of 0.95. The company's 50-day moving average price is $25.57 and its two-hundred day moving average price is $22.33.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same period in the previous year, the company posted $0.24 EPS. Envista's quarterly revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, sell-side analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

About Envista

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Institutional Ownership by Quarter for Envista (NYSE:NVST)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines